– USA, IL – Nexus Pharmaceuticals, Inc., a healthcare company and certified diverse supplier, today announced the appointment of Usman Ahmed as President and CEO effective on October 3, 2022, succeeding Mariam Darsot who will continue as Chair of the Board of Directors.
“Usman brings expertise in operations, vision, and leadership that is essential to an organization dedicated to high-quality patient care and innovation. We are excited about what the future holds for Nexus under Usman’s leadership and believe that this transition is the right step to take the company forward in its next phase of growth,” said Board Chair, Mariam Darsot.
About Usman Ahmed
Usman Ahmed joined Nexus in 2009 as VP of Finance and Business Development before being named CFO in 2013. In 2021, he assumed the role of COO, where he oversaw strategic planning, budgeting, treasury, tax, and corporate development. Prior to joining Nexus, Mr. Ahmed spent three years as an analyst at JP Morgan Chase in their corporate finance program.
He holds a BS Degree in Finance from The Ohio State University.
“I could not be more grateful to accept this position with great respect for what we have already accomplished and what is still possible as an organization,” said Usman Ahmed. “As the healthcare industry continues to evolve, it has become more important than ever for us to ensure that all patients have access to quality medications. I look forward to continuing to work with the Board of Directors, the management team, and our employees – who have helped build this company into what it is today – to ensure its continued success in delivering innovative solutions and patient care when and where it is needed most.”
About Nexus Pharmaceuticals Inc.
Nexus Pharmaceuticals Inc., a US-based healthcare company and certified diverse supplier, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most.
For more information: https://www.nexuspharma.net/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.